Mega Metal Rally! Gold Rockets Past $4,000 as Silver Nears $52 on Debasement Fears

Silver Price Today, November 5, 2025 (5.11.2025): XAG/USD Reclaims $48 as Safe‑Haven Demand Returns; COMEX December Tests $48

Published: Nov 5, 2025

At a glance (intraday, Nov 5):

  • Spot silver rose about 2.2% to $48.13/oz by 2:30 p.m. ET as risk appetite cooled, lifting haven bids. [1]
  • COMEX Dec ’25 silver futures (SI=F) traded between $46.90–$48.06 today. [2]
  • During Asian hours, XAG/USD hovered near $47.60, snapping a three‑day losing streak before pushing higher in U.S. trade. [3]
  • Live wholesale quotes showed spot around $48.24/oz in mid‑U.S. trade. [4]

What moved silver today

Silver advanced alongside gold as investors trimmed risk exposure following stronger‑than‑expected U.S. private payrolls (ADP +42,000). Despite the jobs beat, equities wobbled and haven flows supported precious metals. As of mid‑afternoon New York time, spot silver gained 2.2% to $48.13/oz, with traders also watching a U.S. Supreme Court hearing on the legality of certain tariffs—another macro risk catalyst. [5]

From a cross‑asset lens, bullion’s rebound began in Asia where XAG/USD reclaimed the $47.50 area, aided by softer risk sentiment and a steadier dollar. Momentum carried into Europe and the U.S., where futures probed the $48 handle. [6]

Gold–silver ratio: Using Reuters’ intraday prices (gold ~$3,983.89/oz; silver ~$48.13/oz), the ratio sat near 83, a touch below recent highs—implying silver marginally outperformed gold on the day. [7]


Key prices and ranges (Nov 5, intraday)

  • Spot silver: $48.13/oz (+2.2% on the day, 2:30 p.m. ET). [8]
  • COMEX Dec ’25 (SI=F): Day range $46.90–$48.06. [9]
  • Live wholesale spot snapshot: ~$48.24/oz around late morning U.S. time. [10]

The backdrop: October’s record and a brief London squeeze

Silver is consolidating after a historic October surge above $50/oz, when spot briefly printed fresh records amid gold’s bull run and tight near‑term supply. [11] A subsequent liquidity squeeze in London—which had pushed spot premiums over U.S. futures—eased as shipments from the U.S. and China replenished inventories late last month. Those flows helped normalize pricing and volatility heading into November. [12]

Banks have also lifted their medium‑term outlooks: in August, HSBC raised silver price forecasts for 2025–2027, citing the gravitational pull from elevated gold and persistent macro uncertainty—even as they flagged softer jewelry/coin demand against firm industrial use. [13]


What technicals are signaling

  • Near‑term trend: During Asian trade, buyers defended the mid‑$47s, turning momentum positive into the U.S. session. [14]
  • Indicator dashboard: By Wednesday evening GMT, a widely watched set of momentum studies leaned “Buy/Strong Buy” on XAG/USD (RSI >60, MACD positive), while short‑term oscillators flashed overbought—a setup consistent with a rebound that may pause near resistance. [15]

Levels to watch:

  • Resistance: $49.00–$50.00 (psychological/round‑number zone); a sustained break could re‑expose October’s record area. (Context from recent price behavior.) [16]
  • Support: $47.00–$47.50 (intraday pivot and Asian session base). [17]

Today’s market narrative, in brief

  • Macro impulse: A stronger ADP print didn’t derail precious metals—stocks slipped, and rate‑cut odds for December stayed in play after the Fed’s reduction last week, leaving hedges in favor. [18]
  • Policy/legal watch: Traders tracked the U.S. Supreme Court tariff hearing for potential ramifications on trade‑sensitive metals. [19]
  • Regional color: In India, local press noted softer retail bullion prices heading into the peak wedding/festive season after recent record highs, underscoring the role of currency and taxes in consumer demand. [20]

Why it matters

Silver straddles two demand engines—investment and industry. The structural deficit narrative, supported by robust photovoltaic and electronics demand, helped propel prices to multi‑decade highs this year; even with October’s shakeout, today’s bid shows the theme isn’t spent. (Background on 2025’s deficits and the year’s climb.) [21]


What to watch next

  • U.S. labor data: Weekly claims and Friday’s nonfarm payrolls will steer rate expectations and the dollar—key drivers for silver. (Context on today’s ADP beat.) [22]
  • Spreads & flows: Watch London spot vs. COMEX for signs of renewed tightness or normalization after October’s airlifts. [23]
  • Industrial cues: Any updates on solar/PV installations and electronics output can reinforce the medium‑term deficit story, keeping dips shallow. (Industry‑deficit background.) [24]

Where to track live prices

  • Spot price charts (global wholesale): Kitco live silver. [25]
  • Intraday futures ranges: Exchange‑linked trackers for COMEX silver (e.g., SI=F). [26]
  • Benchmark context: The LBMA Silver Price benchmark (administered by ICE Benchmark Administration) anchors institutional pricing; note licensing applies for real‑time/historical fix data. [27]

Editor’s note & methodology

Figures cited above reference Nov 5, 2025 intraday readings from established market data and news wires; price levels are inherently time‑stamped and subject to change. We relied on Reuters for spot prices and macro drivers, FXStreet for Asia‑session context, Yahoo Finance for the COMEX day range, BullionVault for a live wholesale snapshot, and prior Reuters reporting for October’s record highs and London market dynamics. [28]

This article is for information only and does not constitute investment advice.

They Just Triggered the Final Phase — Gold & Silver Will Never Be the Same Again Andy Schectman

References

1. www.reuters.com, 2. finance.yahoo.com, 3. www.fxstreet.com, 4. www.bullionvault.com, 5. www.reuters.com, 6. www.fxstreet.com, 7. www.reuters.com, 8. www.reuters.com, 9. finance.yahoo.com, 10. www.bullionvault.com, 11. www.reuters.com, 12. www.reuters.com, 13. www.reuters.com, 14. www.fxstreet.com, 15. www.investing.com, 16. www.reuters.com, 17. www.fxstreet.com, 18. www.reuters.com, 19. www.reuters.com, 20. maharashtratimes.com, 21. www.reuters.com, 22. www.reuters.com, 23. www.reuters.com, 24. www.reuters.com, 25. www.kitco.com, 26. finance.yahoo.com, 27. www.lbma.org.uk, 28. www.reuters.com

Stock Market Today

  • GE-Shen Corporation Berhad: Is Weak ROE a Signal of a Market Correction for KLSE:GESHEN?
    November 6, 2025, 1:18 AM EST. GE-Shen Corporation Berhad (KLSE:GESHEN) has fallen 5.4% over three months, raising questions about whether weaker fundamentals herald a market correction. Its trailing ROE is 7.7% (to June 2025), above the industry average of 5.3%, yet not stellar. The company posted a strong five-year net income growth of 27%, even as industry earnings fell 6.9%. The higher ROE with steady growth suggests earnings potential is there, but other factors like payout policy and reinvestment may influence future performance. In short, the stock's decline isn't only about ROE; investors should assess whether growth expectations are priced in and whether the current price reflects the risk and upside of GE-Shen's earnings trajectory.
  • Ethereum Sell-off Drags BitMine Immersion Technologies (BMNR) Lower as ETH Holdings Drive Valuation
    November 6, 2025, 1:14 AM EST. Shares of BitMine Immersion Technologies (BMNR) slumped as a rout in Ethereum (ETH) dragged down the stock tied to crypto holdings. BMNR controls a vast ETH treasury, reportedly owning about 2.8% of the total supply and aiming for 5%. With ETH dropping about 5.7% and hitting mid-June lows, the value of BMNR's core asset declines, pressuring the stock. The broader cryptocurrency market weakness, including BTC below $101,000 and heavy liquidations, amplified a risk-off move away from crypto-exposed equities like BMNR. Benzinga Edge shows a high Momentum score for BMNR (99.59), reflecting investor enthusiasm despite the downside. Trading action placed BMNR around the mid-$39s, down about 7% at publication. Investors should monitor ETH price, treasury strategy, and any company disclosures on liquidity and hedging.
  • Solana, HBAR, and Litecoin ETFs Buck Market Panic as BTC and ETH ETFs Suffer $800M in Outflows
    November 6, 2025, 1:10 AM EST. The crypto rout on Nov. 4 saw BTC fall below $100,000 and ETH slip under $3,150, erasing roughly $3.5 trillion in market value. Yet three newer altcoin ETFs bucked the trend: Solana (SOL), HBAR, and Litecoin (LTC) gathered fresh capital and posted net inflows on every trading day since their late-October launches. By contrast, major Bitcoin and Ethereum ETFs recorded heavy outflows: Bitcoin funds shed about $577 million that day, led by Fidelity's FBTC, with ARKB at $128 million and others largely flat or liquidating; Ethereum products saw about $273.5 million in daily outflows, led by ETHA $111 million, Grayscale, and FETH. The divergence hints at growing appetite for altcoin exposure amid a broader market pullback.
  • Michael Burry Bets $1B Against AI Rally with Nvidia and Palantir Puts
    November 6, 2025, 1:08 AM EST. Michael Burry's Scion Asset Management is betting that the AI rally will falter, buying roughly $1 billion in put options: $187.6M on Nvidia and $912M on Palantir. The bet echoes his famed 2008 housing short, though there's no certainty of a crash. Nvidia's market cap recently topped $5 trillion, and Palantir trades at a lofty multiple, fueling concerns about an AI bubble. The stock reaction was muted-to-sluggish, with Nvidia and Palantir slipping after the disclosures. Critics point to circular financing and richly valued AI names as red flags for a broader unwind. Burry resurfaced on X, posting a nod to his Big Short fame and noting that "sometimes bubbles pop," while urging caution rather than chasing hype. CNN and The Telegraph covered the filings.
  • Evommune Debuts on NYSE with $150M IPO Amid Federal Shutdown
    November 6, 2025, 1:06 AM EST. Evommune priced a $150 million IPO, selling nearly 9.4 million shares at $16 and listing on the NYSE under ticker EVMN. The Palo Alto biopharma is among a handful using a little-used Securities Act provision to price during the federal shutdown via an amended registration that auto-prices after 20 days. Its pipeline includes EVO756, an oral candidate targeting MRGPRX2 for chronic spontaneous urticaria and atopic dermatitis, and EVO301, a mid-stage therapy for atopic dermatitis that binds IL-18. Evommune acquired EVO301 from AprilBio for up to $460 million. Pre-IPO financing totaled about $267 million from investors like EQT Life Sciences, Pivotal bioVenture Partners, and RA Capital. Through 2025, only about a dozen biotech IPOs priced.
Gold Soars Past $4,000 for the First Time – Inside the Historic Rally and What’s Next
Previous Story

Gold Price Today, November 5, 2025: Spot nears $3,984 as risk‑off tone returns; ADP +42k and Fed caution keep $4,000 in play

Northern Lights Alert! Solar Storms, Draconid Meteors & a Bright Harvest Moon Dazzle Oct. 8–9, 2025
Next Story

Night Sky in November 2025: Biggest Supermoon of the Year, Leonids Meteor Shower, Uranus at Opposition & More

Go toTop